Penn spinout Vivodyne raises $38M to advance platform making lab-grown human organs for new drug testing

Vivodyne's platform is designed to improve the discovery and development of drug candidates by testing them — using robots — directly on thousands of lifelike, lab-grown human organ tissues simultaneously.